Clara Rodríguez Fernández, Author at Labiotech.eu - Page 62 of 63

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

News and Trends 30 Sep 2016

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company’s CFO, who explained its advantageous position against big pharma. GeNeuro raised €33M in its Euronext IPO in April and is currently competing against giants like Novartis and Biogen. Despite 2016’s dubious honor as “the worst year for IPO in 20 years”, this Switzerland-based company has managed to go […]

September 30, 2016 - 1 minutemin - By Clara Rodríguez Fernández

shutterstock 361549328

News and Trends 29 Sep 2016

Boehringer buys a €210M ticket to Virus-based Immuno-Oncology

Boehringer Ingelheim has signed a deal with ViraTherapeutics, an Austrian start-up that focuses on the development of oncolytic virus therapies. If everything goes well, the big Pharma could acquire the Biotech start-up after completion of Phase I trials. Boehringer Ingelheim has its eye on ViraTherapeutics’ oncolytic virus platform. The young Biotech’s technology establishes a novel treatment approach that […]

September 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 117198280 1 e1474987771873

News and Trends 29 Sep 2016

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off treatment. But all that glitters is not gold; experts remind us it is important to be critical about the immuno-oncology hype. Immuno-oncology has become all the rage lately, and the hype has led to some major investments, acquisitions, deals and partnerships. It seems […]

September 29, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

shutterstock 238249900 e1475071024611

News and Trends 28 Sep 2016

Biotech is one of the biggest Employers in Europe

As part of the European Biotech Week, EuropaBio shared yesterday a study revealing that Industrial Biotech has created 486,000 full-time jobs and contributes €31.6B to the EU. This new data emphasizes the huge role that Biotech plays on the continent’s economy. The biotech industry was in the spotlight this week at the European Parliament, where the report was presented, and it […]

September 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 154369652

News and Trends 24 Sep 2016

The Future of Portugal as explained by Microorganisms

Microbiology makes its mark at the first edition of the London Design Biennale taking place in Somerset House. Portugal’s exhibition by Marta de Menezes uses bacteria and viruses to create changing art that represents the future direction of the country. With the common topic “Design by Utopia“, 30 nations have interpreted utopic and dystopic futures using art to […]

September 24, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Kidney

News and Trends 22 Sep 2016

Evotec and Bayer renew their vows and take on Kidney Disease

Evotec and Bayer are approaching the 4th anniversary of a successful partnership in endometriosis treatments that made it to clinical trials just last month. To celebrate, they’re starting a new 5-year partnership, this time concerning kidney disease. Evotec has a long list of top-level partners, including Roche, Sanofi, Boehringer Ingelheim and Takeda. After the successful outcome of […]

September 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

liver nash Elen Bushe fi

News and Trends 22 Sep 2016

After only 6 months, Akarna seals the deal with Allergan for €44.8M upfront

Earlier this week, we announced the launch of a new diagnostic tool for NASH by the French company Genfit. Now, Ireland strikes back with the acquisition of Akarna with a €44.8M upfront payment. Akarna focuses on the development of drugs for Non-Alcoholic Steato-Hepatitis (NASH) and boasts to count with a potentially best-in-class therapeutic candidate still in preclinical trials. The […]

September 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

dna hywards fi

News and Trends 21 Sep 2016

A new player has entered the Game: €29M for DDR Cancer Therapy

Artios Pharma, launched in May this year, just received €29M (£25M) in Series A to develop cancer treatments. Its technology targets the DNA-Damage Response (DDR) and could overcome one of the main challenges of cancer therapy. Top-notch investors from Europe and the US have eagerly thrown cash at Artios Pharma in their search for new cancer treatments. […]

September 21, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

tumor nanoparticles Kateryna Kon FI

News and Trends 20 Sep 2016

This company just turned the lights ON for NanoMed Bioplastic

Bio-ON just patented the first application of bioplastic in nanomedicine with a diagnostic tool for cancer that will grant it access to a whole new market previously inaccessible to this industry. Italy-based Bio-ON is trying to change the world by producing alternative sustainable chemicals and bioplastic materials with industrial applications. Their newest product, minerv BIOMEDS, will be used […]

September 20, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

liver health EtoileArk FI

News and Trends 20 Sep 2016

Genfit’s Non-Invasive Diagnostic could unlock the NASH Market

Genfit reinforced its leading place in the race to find a cure for NASH when it announced this morning the launch of a program to validate their new diagnostic tool. Genfit is already leading in the development of a cure for Non-Alcoholic Stato-Hepatitis (NASH) with its candidate, Elafibranor, which is in Phase III trials. Now, the French €600M biopharma has […]

September 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

chromosome koya979 FI

News and Trends 19 Sep 2016

Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen

Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian biotech from Milan raised €10M in series A funding last year and is already getting ready for clinical trials. Genenta is developing a gene therapy platform for haematopoietic stem cells and wants to bring it to the clinic. Together with the San Raffaele Hospital and Scientific […]

September 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Accelerators And Biotech Startups cover

In Depth 23 Aug 2016

5 Expert Tips to Success When Building a Biotech Startup

Succeeding as an entrepreneur is tough, you will have to deal with failure and learn from it along the way. Many new biotech startups face similar problems during their early steps, here are some expert tips on how to avoid them. Last week, I had the opportunity to meet Mark Hammond and Dominic Falcao, who […]

August 23, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT